Suchergebnisse - (Person:"Jimenez-Fonseca, Paula")

PubPharm (14)

1

Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON-SEOM registry

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2024

von Arias-Martinez, A. | Martínez de Castro, E. | Gallego, J. | +28

2

Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry

enthalten in: Journal of cancer research and clinical oncology | 2023

von Valcarcel, S. | Gallego, J. | Jimenez-Fonseca, P. | +26

3

Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry

enthalten in: Journal of cancer research and clinical oncology | 2022

von Valcarcel, S. | Gallego, J. | Jimenez-Fonseca, P. | +26

4

Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry

enthalten in: Journal of cancer research and clinical oncology | 2022

von Valcarcel, S. | Gallego, J. | Jimenez-Fonseca, P. | +26

5

The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasms

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Borbath, I. | Garcia-Carbonero, R. | Bikmukhametov, D. | +11

6

External Validity of Somatostatin Analogs Trials in Advanced Neuroendocrine Neoplasms : The GETNE-TRASGU Study

enthalten in: Neuroendocrinology | 2022

von Jimenez-Fonseca, P. | Carmona-Bayonas, A. | Lamarca, A. | +25

7

Bayesian interpretation of immunotherapy trials with dynamic treatment effects

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Castañon, E. | Sanchez-Arraez, �. | Jimenez-Fonseca, P. | +4

8

Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2021

von Alvarez-Manceñido, F. | Jimenez-Fonseca, P. | Carmona-Bayonas, A. | +31

9

External validity of docetaxel triplet trials in advanced gastric cancer : are there patients who still benefit?

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2021

von Jimenez-Fonseca, P. | Carmona-Bayonas, A. | Martínez de Castro, E. | +31

10

Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry

enthalten in: Gastric cancer | 2021

von Alvarez-Manceñido, F. | Jimenez-Fonseca, P. | Carmona-Bayonas, A. | +31